Tuesday, September 15, 2026

New Fat Reduction Injection Shows 73.7% Success in Phase 3 Trial

AMIPHARM reveals promising phase 3 results for AYP-101, a fat reduction injection, at IMCAS 2026, targeting submental fat safely.

Lotte Global Logistics Expands High-Value BESS Transport: What This Means for the EV Market

Lotte Global Logistics is expanding its high-value special cargo business by increasing inland transportation for LG Energy Solution's BESS in the U.S.

Kolmar BNH Wins Global HACCP at Two Plants: Raising Food Safety Standards to a Global Level

Kolmar BNH becomes the first health supplement ODM to achieve Global HACCP certification, enhancing food safety management standards.

Health

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.
Latest

Novo Nordisk Launches Clinical Trials for Next-Gen Obesity Drug ZenaGamtide in Asia: What to Expect?

Novo Nordisk begins domestic Phase 3 trials for obesity treatment candidate ZenaGamtide, competing with Eli Lilly's market leader.

Understanding Differences of Sex Development: The Story of a Woman with XY Chromosomes

A woman discovered she has testicles and XY chromosomes after seeking medical help due to delayed menstruation.

Child Mask Sales Skyrocket 341% Amid COVID-19 Spike: What This Means for Parents

As COVID-19 cases rise again, convenience stores see increased demand for self-protection items like test kits, cold medicine, and masks.

Unlocking the Future: Why 340,000 Families Trust Celltrion’s Cord Blood Banking in 2026

Medipost announces that its brand, Celltrion, has surpassed 340,000 cord blood storage units in South Korea.

Samsung Biologics Launches 3 Billion USD Stock Offering to Acquire Polypeptide Group: What This Means for the Global CDMO Market

Samsung Biologics plans a 2.3 billion USD capital increase to become a top-tier CDMO, primarily for acquiring Polypeptide Group.

K-Beauty Revolution: How Korean Medical Aesthetic Devices Are Dominating Global Markets

South Korea's skin beauty medical device companies are continuing to grow, focusing on the overseas market.

Unlocking the Future: How Genomic Testing Enhances GLP-1 Obesity Treatment for Asian Patients

NGeneBio is developing tests to identify which patients benefit from GLP-1 weight loss drugs like Wegovy and Mounjaro, assessing side effects.

AI in Healthcare: How SEERS is Revolutionizing Arrhythmia Diagnosis in the UAE

SEERS is advancing the commercialization of AI-based arrhythmia diagnosis in the UAE, expanding its reach in the Middle East market.

Daiwoong Pharmaceuticals Secures U.S. Patent for Revolutionary Anti-Aging mRNA Delivery Technology

Daewoong Pharmaceutical is close to securing a U.S. patent for a key drug delivery technology for developing anti-aging treatments.

SOT106: The Groundbreaking ADC Cancer Drug Fast-Tracked by FDA for Soft Tissue Sarcoma

LigaChem Biosciences' antibody-drug conjugate (ADC) cancer treatment candidate has received Fast Track designation from the FDA.

SK Biopharmaceuticals Secures 795 Million USD License for Groundbreaking Epilepsy Drug Opacalim – What You Need to Know

SK Biopharmaceuticals acquires epilepsy drug candidate from Biohaven for 795 million USD, enhancing its global biotech portfolio.

Revolutionary Wireless Neural Implant: Remote Brain Control from the U.S. to Korea

South Korean researchers developed a wireless device to remotely control a brain implant, delivering drugs and precisely regulating neurons.

Discover TEN’s New Single “OUTWEST”: A Complete Guide to His Upcoming U.S. Tour

Artist Ten expands global influence with his first solo US showcase tour, recently announcing it through an official poster.

Neurophet Partners with Elevate Clinic: How AI is Transforming Brain Injury Diagnosis in the US

Neurophet signs supply contracts with Elevate Clinic for Neurophet Aqua and Neurofit Aqua AD Plus in the U.S. market.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.